Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
1(20%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
5
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
N/ANon-phased studies
5(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(4)

Detailed Status

Completed4
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A5 (100.0%)

Trials by Status

completed480%
recruiting120%

Recent Activity

1 active trials
Showing 5 of 5
recruitingnot_applicable

Implementation and Cost Evaluation of Project UPLIFT

NCT06865820
completednot_applicable

Project Uplift: Substance Use and Mental Health Treatment for Young Sexual and Gender Minorities

NCT04546061
completednot_applicable

Project UPLIFT for Psychogenic Non-Epileptic Seizures

NCT03329703
completednot_applicable

Adapting Project UPLIFT for Blacks in Georgia

NCT02909387
completednot_applicable

Preventing Depression in People With Epilepsy: an Extension of Project UPLIFT

NCT01941706

Clinical Trials (5)

Showing 5 of 5 trials
NCT06865820Not Applicable

Implementation and Cost Evaluation of Project UPLIFT

Recruiting
NCT04546061Not Applicable

Project Uplift: Substance Use and Mental Health Treatment for Young Sexual and Gender Minorities

Completed
NCT03329703Not Applicable

Project UPLIFT for Psychogenic Non-Epileptic Seizures

Completed
NCT02909387Not Applicable

Adapting Project UPLIFT for Blacks in Georgia

Completed
NCT01941706Not Applicable

Preventing Depression in People With Epilepsy: an Extension of Project UPLIFT

Completed

All 5 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
5